$2.08
0.189.16%
At close: Aug 6, 5:00 PM EST
$2.03
0.126.28%
Pre-Market: 7:49 AM EST
INmune Bio Inc
INMBNASDAQ
Earnings: Q2 2026 Earnings were released on Thu Aug 6th, after the market close
Conference Call: The most recent conference call started at 4:30 PM, 4 days agoClick to view the webcast
INmune Bio Earnings & Forecasts
INmune Bio (INMB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
INmune Bio Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.20 | $-0.21 | $-0.27 | $-0.32 |
| Actual | $-0.05 | $-0.20 | $-0.18 | $-0.24 |
| Surprise | +75.0% | +4.76% | +33.3% | +25.0% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | — | $0 | $0 | $0 |
| Surprise | — | — | — | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.17 | $-0.15 |
| Revenue | ||
| Consensus | — | — |
